FI86428C - Foerfarande foer framstaellning av terapeutiskt aktiva 10-substituerad-9-fluor-7-oxo-2,3-dihydro-7h-pyrido -/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat. - Google Patents
Foerfarande foer framstaellning av terapeutiskt aktiva 10-substituerad-9-fluor-7-oxo-2,3-dihydro-7h-pyrido -/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat. Download PDFInfo
- Publication number
- FI86428C FI86428C FI873940A FI873940A FI86428C FI 86428 C FI86428 C FI 86428C FI 873940 A FI873940 A FI 873940A FI 873940 A FI873940 A FI 873940A FI 86428 C FI86428 C FI 86428C
- Authority
- FI
- Finland
- Prior art keywords
- oxo
- compound
- methyl
- dihydro
- pyrido
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI904279A FI88041C (fi) | 1986-09-12 | 1990-08-30 | Pyrido/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat |
| FI904278A FI93357C (fi) | 1986-09-12 | 1990-08-30 | 8-hydroksi-1-amino-4-okso-1,4-dihydro-3-kinoliinijohdannaisia |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP86112619 | 1986-09-12 | ||
| EP86112619 | 1986-09-12 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI873940A0 FI873940A0 (fi) | 1987-09-11 |
| FI873940A FI873940A (fi) | 1988-03-13 |
| FI86428B FI86428B (fi) | 1992-05-15 |
| FI86428C true FI86428C (fi) | 1992-08-25 |
Family
ID=8195410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI873940A FI86428C (fi) | 1986-09-12 | 1987-09-11 | Foerfarande foer framstaellning av terapeutiskt aktiva 10-substituerad-9-fluor-7-oxo-2,3-dihydro-7h-pyrido -/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat. |
Country Status (22)
| Country | Link |
|---|---|
| JP (3) | JPH0696578B2 (da) |
| KR (1) | KR960002857B1 (da) |
| CN (1) | CN1017800B (da) |
| AT (1) | AT389119B (da) |
| AU (1) | AU602534B2 (da) |
| CA (1) | CA1336905C (da) |
| CZ (1) | CZ281195B6 (da) |
| DK (1) | DK173330B1 (da) |
| DZ (1) | DZ1124A1 (da) |
| FI (1) | FI86428C (da) |
| HU (1) | HU199481B (da) |
| IE (1) | IE61624B1 (da) |
| IL (1) | IL83814A (da) |
| MC (1) | MC1850A1 (da) |
| MX (1) | MX8302A (da) |
| NO (1) | NO169125C (da) |
| NZ (1) | NZ221681A (da) |
| PH (1) | PH23930A (da) |
| PT (1) | PT85686B (da) |
| SK (1) | SK278990B6 (da) |
| ZA (1) | ZA876636B (da) |
| ZW (1) | ZW16387A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW16387A1 (en) * | 1986-09-12 | 1988-05-25 | Hoffmann La Roche | Tricyclic compounds |
| EP1757598A4 (en) | 2004-05-13 | 2010-07-21 | Daiichi Seiyaku Co | SUBSTITUTED PYRROLIDINE DERIVATIVE |
| US7563805B2 (en) * | 2005-05-19 | 2009-07-21 | Daiichi Pharmaceutical Co., Ltd. | Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| CN101443314B (zh) | 2006-03-13 | 2014-04-09 | 杏林制药株式会社 | 作为gsk-3抑制剂的氨基喹诺酮类 |
| JP5426552B2 (ja) | 2007-09-11 | 2014-02-26 | 杏林製薬株式会社 | Ｇｓｋ−３阻害剤としてのシアノアミノキノロン及びテトラゾロアミノキノロン |
| MX2010002662A (es) | 2007-09-12 | 2010-04-09 | Activx Biosciences Inc | Aminoquinolonas espirociclicas como inhibidores de gsk-3. |
| FR2928150A1 (fr) * | 2008-02-29 | 2009-09-04 | Vetoquinol Sa Sa | Nouveaux derives 7-substitues de 3-carboxy-oxadiazino-quinolones, leur preparation et leur application comme anti-bacteriens |
| EP2145891A1 (en) * | 2008-07-09 | 2010-01-20 | Vetoquinol S.A. | 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| WO2010104205A1 (en) | 2009-03-11 | 2010-09-16 | Kyorin Pharmaceutical Co., Ltd. | 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
| CN107522718B (zh) * | 2017-09-14 | 2019-11-08 | 浙江国邦药业有限公司 | 一种马波沙星的合成方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW16387A1 (en) * | 1986-09-12 | 1988-05-25 | Hoffmann La Roche | Tricyclic compounds |
-
1987
- 1987-08-28 ZW ZW163/87A patent/ZW16387A1/xx unknown
- 1987-09-04 ZA ZA876636A patent/ZA876636B/xx unknown
- 1987-09-04 NZ NZ221681A patent/NZ221681A/en unknown
- 1987-09-07 AU AU78114/87A patent/AU602534B2/en not_active Expired
- 1987-09-07 IL IL83814A patent/IL83814A/xx not_active IP Right Cessation
- 1987-09-09 DZ DZ870149A patent/DZ1124A1/fr active
- 1987-09-09 HU HU874007A patent/HU199481B/hu unknown
- 1987-09-10 MC MC871911A patent/MC1850A1/xx unknown
- 1987-09-11 KR KR1019870010082A patent/KR960002857B1/ko not_active IP Right Cessation
- 1987-09-11 FI FI873940A patent/FI86428C/fi not_active IP Right Cessation
- 1987-09-11 DK DK198704772A patent/DK173330B1/da not_active IP Right Cessation
- 1987-09-11 IE IE244487A patent/IE61624B1/en not_active IP Right Cessation
- 1987-09-11 NO NO873816A patent/NO169125C/no unknown
- 1987-09-11 SK SK6604-87A patent/SK278990B6/sk unknown
- 1987-09-11 PT PT85686A patent/PT85686B/pt unknown
- 1987-09-11 CZ CS876604A patent/CZ281195B6/cs not_active IP Right Cessation
- 1987-09-11 CA CA000546674A patent/CA1336905C/en not_active Expired - Lifetime
- 1987-09-11 PH PH35800A patent/PH23930A/en unknown
- 1987-09-12 CN CN87106838A patent/CN1017800B/zh not_active Expired
- 1987-09-12 JP JP62227579A patent/JPH0696578B2/ja not_active Expired - Fee Related
- 1987-09-14 MX MX830287A patent/MX8302A/es unknown
- 1987-10-08 AT AT0263887A patent/AT389119B/de not_active IP Right Cessation
-
1994
- 1994-05-25 JP JP6133905A patent/JPH0819120B2/ja not_active Expired - Lifetime
- 1994-05-25 JP JP6133894A patent/JPH0826030B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0237955B1 (en) | Quinolonecarboxylic acid derivatives and their preparation | |
| US5312823A (en) | 7-azaisoindolinyl-quinolone-carboxylic acid derivatives | |
| US4801584A (en) | Pyrido(3,2,1-IJ)-1,3,4 benzoxadiazine derivatives | |
| US4843070A (en) | Substituted thiazetoquinoline-3-carboxylic acids and pharmaceutically acceptable salts thereof | |
| HU179927B (en) | Process for preparing naphthyridine derivatives | |
| HU208130B (en) | Process for producing 7-(1-pyrrolidinyl)-3-quinoline and naphthyridinecarboxylic acid derivatives and antibacterial agents and fodder additives comprising such compounds | |
| FI86428C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 10-substituerad-9-fluor-7-oxo-2,3-dihydro-7h-pyrido -/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat. | |
| GB2158825A (en) | Naphthyridines | |
| DK165635B (da) | 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxy-derivater, farmaceutisk praeparat omfattende saadanne forbindelser, samt fremgangsmaade til fremstilling af forbindelserne | |
| IE65732B1 (en) | Heterocylic-substituted quinoline-carboxylic acids | |
| US4864023A (en) | Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives | |
| KR940006595B1 (ko) | 피리돈카르복실산의 아제티딘 유도체, 그의 제조방법 및 이를 함유하는 의약품조성물 | |
| DK161457B (da) | Quinolincarboxylsyreforbindelse eller hydrater eller farmaceutisk acceptable salte deraf, fremgangsmaade til deres fremstilling samt antibakterielle farmaceutiske praeparater indeholdende disse | |
| CZ280594A3 (en) | Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid and 1-(2-fluorocyclopropyl)-naphthyridonecarboxylic acid, process of their preparation and use in medicaments | |
| FI88041B (fi) | Pyrido/3,2,1-ij/-1,3,4-bensoxadiazin-6-karboxylsyraderivat | |
| JPH08253480A (ja) | １，６−ナフチリドンカルボン酸誘導体 | |
| NO171162B (no) | Pyrido-benzoksadiazinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Patent granted |
Owner name: F. HOFFMANN-LA ROCHE AG |
|
| MA | Patent expired |